What does Organogenesis Holdings, Inc. do?

Jun 22 2025 07:03 PM IST
share
Share Via
Organogenesis Holdings, Inc. is a regenerative medicine company specializing in advanced wound care, surgical, and sports medicine products. As of March 2025, it reported net sales of $87 million and a net loss of $19 million, with a market cap of $399.33 million.
Overview:
Organogenesis Holdings, Inc. is a regenerative medicine company that focuses on the development, manufacture, and commercialization of product solutions for advanced wound care, surgical, and sports medicine markets, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 87 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -19 Million (Quarterly Results - Mar 2025)
Market cap: USD 399.33 Million (Micro Cap)

Key Metrics:
P/E: 28.00
Dividend Yield: 0.00%
Debt Equity: -0.28
Return on Equity: 3.72%
Price to Book: 1.08

Contact Details:
Address: 85 Dan Rd, CANTON MA : 02021-2810
Tel: 1 781 5750775
Website: https://investors.organogenesis.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News